We have shown that UCHL5 promotes TGFβ signaling via stabilization of Smad2/Smad3 and may be a potential therapeutic target to block the differentiation of myofibroblasts and the expression of matrix in IPF. This evidence concerns the gene SMAD2 and idiopathic pulmonary fibrosis.